Heart rate variability and plasma biomarkers in patients with type 1 diabetes mellitus: Effect of a bout of aerobic exercise

Diabetes Research and Clinical Practice

Volumn 111, Issue , 2016, Pages 19-27

  Anaruma, Chadi P ^a   Ferreira, Maycon ^a   Sponton, Carlos H G ^a   Delbin, Maria A ^b   Zanesco, Angelina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Acute aerobic exercise; Blood glucose; Heart rate variability; NOx ; Thiobarbituric acid reactive substances (TBARS); Type 1 diabetes mellitus

Indexed keywords

6 N CARBOXYMETHYLLYSINE; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; ISOPHANE INSULIN; LACTIC ACID; NITRATE; NITRITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE RECOVERY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART RATE VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPID PEROXIDATION; MALE; MORNING DOSAGE; OXYGEN CONSUMPTION; RR INTERVAL; TREADMILL EXERCISE; ADOLESCENT; ANALYSIS; BLOOD; CONTROLLED CLINICAL TRIAL; EXERCISE; EXERCISE TEST; FEMALE; HEART RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EXERCISE; EXERCISE TEST; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; YOUNG ADULT;

EID: 84957551397     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.10.025     Document Type: Article

References (35)

1. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17(1):24-38.
2. Schalkwijk C.G., Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 2005, 109(2):143-159.
3. Goldin A., Beckman J.A., Schmidt A.M., Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114(6):597-605.
4. Frey R.S., Ushio-Fukai M., Malik A.B. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 2009, 11(4):791-810.
5. Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiol Rev 2013, 93(1):137-188.
6. Libby P., Nathan D.M., Abraham K., Brunzell J.D., Fradkin J.E., Haffner S.M., et al. National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation 2005, 111(25):3489-3493.
7. Vinik A.I., Erbas T. Diabetic autonomic neuropathy. Handb Clin Neurol 2013, 117:279-294.
8. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996, 17(3):354-381.
9. Billman G.E., Huikuri H.V., Sacha J., Trimmel K. An introduction to heart rate variability: methodological considerations and clinical applications. Front Physiol 2015, 6:55.
10. Bernardi L., Ricordi L., Lazzari P., Soldá P., Calciati A., Ferrari M.R., et al. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 1992, 86(5):1443-1452.
11. Vinik A.I., Maser R.E., Mitchell B.D., Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003, 26(5):1553-1579.
12. Tannus L.R., Sperandei S., Montenegro Júnior R.M., Carvalho V.R., Pedrosa H.C., Félix M.T., et al. Reproducibility of methods used for the assessment of autonomous nervous system's function. Auton Neurosci 2013, 177(2):275-279.
13. American Diabetes Association Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997, 20:S3-S13.
14. Fiuza-Luces C., Garatachea N., Berger N.A., Lucia A. Exercise is the real polypill. Physiology 2013, 28(5):330-358.
15. International Diabetes Federation Diabetes Atlas 2013, 6th ed.
16. Widrick J., Ward A., Ebbeling C., Clemente E., Rippe J.M. Treadmill validation of an over-ground walking test to predict peak oxygen consumption. Eur J Appl Physiol Occup Physiol 1992, 64(4):304-308.
17. Karvonen M.J., Kentala E., Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn 1957, 35(3):307-315.
18. Eengels R.C., Jones J.B. Causes and elimination of erratic blanc in enzymatic metabolic assays involving the use of NAD in alkaline hydrazine buffers: improved conditions for assay of l-glutamate, l-lactate and other metabolites. Anal Biochem 1978, 88:475-484.
19. Rosenstock J., Bergenstal R.M., Blevins T.C., Morrow L.A., Prince M.J., Qu Y., et al. Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study. Diabetes Care 2013, 36(3):522-528.
20. Galler A., Müller G., Schinzel R., Kratzsch J., Kiess W., Münch G. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA. Diabetes Care 2003, 26(9):2609-2615.
21. Lieuw-A-Fa M.L., van Hinsbergh V.W., Teerlink T., Barto R., Twisk J., Stehouwer C.D., et al. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrol Dial Transplant 2004, 19(3):631-636.
22. Nin J.W., Jorsal A., Ferreira I., Schalkwijk C.G., Prins M.H., Parving H.H., et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 2011, 34(2):442-447.
23. Ruiz C., Alegría A., Barberá R., Farré R., Lagarda M.J. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1999, 59(2):99-105. Apr.
24. Fayh A.P., Krause M., Rodrigues-Krause J., Ribeiro J.L., Ribeiro J.P., Friedman R., et al. Effects of l-arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type I diabetes. Eur J Nutr 2013, 52(3):975-983.
25. Mylona-Karayanni C., Gourgiotis D., Bossios A., Kamper E.F. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link. Pediatr Diabetes 2006, 7(1):51-59. Feb.
26. Horoz O.O., Yuksel B., Bayazit A.K., Attila G., Sertdemir Y., Mungan N.O., et al. Ambulatory blood pressure monitoring and serum nitric oxide concentration in type 1 diabetic children. Endocr J 2009, 56(3):477-485.
27. Smulders R.A., Stehouwer C.D., Olthof C.G., van Kamp G.J., Teerlink T., de Vries P.M., et al. Plasma endothelin levels and vascular effects of intravenous l-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994, 87(1):37-43.
28. Ferlito S., Gallina M. Nitrite plasma levels in type 1 and 2 diabetics with and without complications. Minerva Endocrinol 1999, 24(3-4):117-121.
29. Farkas K., Jermendy G., Herold M., Ruzicska E., Sasvári M., Somogyi A. Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2004, 112(5):258-263.
30. Woo J., Yeo N.H., Shin K.O., Lee H.J., Yoo J., Kang S. Antioxidant enzyme activities and DNA damage in children with type 1 diabetes mellitus after 12 weeks of exercise. Acta Paediatr 2010, 99(8):1263-1268.
31. Ewing D.J., Neilson J.M., Travis P. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. Br Heart J 1984, 52(4):396-402.
32. Turker Y., Aslantas Y., Aydin Y., Demirin H., Kutlucan A., Tibilli H., et al. Heart rate variability and heart rate recovery in patients with type 1 diabetes mellitus. Acta Cardiol 2013, 68(2):145-150.
33. Jaiswal M., Fingerlin T.E., Urbina E.M., Wadwa R.P., Talton J.W., D'Agostino R.B., et al. Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Technol Ther 2013, 15(12):977-983.
34. Cole C.R., Blackstone E.H., Pashkow F.J., Snader C.E., Lauer M.S. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999, 341(18):1351-1357.
35. Myers J., Tan S.Y., Abella J., Aleti V., Froelicher V.F. Comparison of the chronotropic response to exercise and heart rate recovery in predicting cardiovascular mortality. Eur J Cardiovasc Prev Rehabil 2007, 14(2):215-221.